The Global. Portugal goes a step further in its strategy to promote the use of biosimilars in the country with the establishment of a minimum quota of use of biosimilars of 20 percent in all its hospitals. This has been confirmed by the Portuguese National Authority for Medicines and Health Products (Infarmed) with the publication of an information note indicating the adoption of this minimum quota for 2017.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
